We are live on ! Find out more
IART icon

Integra LifeSciences
IART

210 hedge funds and large institutions have $2.67B invested in Integra LifeSciences in 2016 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 71 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,779% more call options, than puts

Call options by funds: $2.99M | Put options by funds: $104K

113% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 16

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

22% more capital invested

Capital invested by funds: $2.2B → $2.67B (+$473M)

13% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 71

8% more funds holding

Funds holding: 194 → 210 (+16)

Holders
210
Holders Change
+16
Holders Change %
+8.25%
% of All Funds
5.6%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
34
Increased
80
Reduced
71
Closed
16
Calls
$2.99M
Puts
$104K
Net Calls
+$2.89M
Net Calls Change
+$2.68M

Top Buyers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
+$51.1M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$36.8M
3
CCI
Columbus Circle Investors
+$28.4M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$23.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.8M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$22.1M
2
EIP
Epoch Investment Partners
New York
-$20M
3
FA
Friess Associates
Delaware
-$19M
4
Citadel Advisors
Citadel Advisors
Florida
-$15.9M
5
Millennium Management
Millennium Management
New York
-$15.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capstone Investment Advisors
151
Capstone Investment Advisors
New York
$366K +$331K +9,200 New
ProShare Advisors
152
ProShare Advisors
Maryland
$347K +$15.5K +432 +5%
MC
153
Miles Capital
Iowa
$340K +$4.53K +126 +2%
NIC
154
Northwest Investment Counselors
Oregon
$339K -$576 -16 -0.2%
TSS
155
Two Sigma Securities
New York
$331K +$298K +8,286 New
PM
156
Parametrica Management
Hong Kong
$325K +$294K +8,158 New
CCA
157
Conestoga Capital Advisors
Pennsylvania
$319K – – –
PA
158
Profund Advisors
Maryland
$313K -$144 -4 -0.1%
SCM
159
Stevens Capital Management
Pennsylvania
$295K +$266K +7,384 New
PP
160
Paloma Partners
Connecticut
$295K +$266K +7,400 New
OSAM
161
O'Shaughnessy Asset Management
Connecticut
$294K -$712K -19,794 -73%
PI
162
PineBridge Investments
New York
$293K +$11.1K +308 +4%
AB
163
Amalgamated Bank
New York
$292K +$33.1K +920 +15%
PPCM
164
Pillar Pacific Capital Management
California
$280K – – –
PAM
165
Princeton Alpha Management
New Jersey
$279K +$251K +6,990 New
WB
166
WesBanco Bank
West Virginia
$271K +$244K +6,788 New
BC
167
Burney Company
Virginia
$270K +$13.7K +380 +6%
Citigroup
168
Citigroup
New York
$252K -$1.39M -38,694 -86%
Bank of Montreal
169
Bank of Montreal
Ontario, Canada
$252K -$20.6K -572 -8%
IMAS
170
ID Management A/S
Denmark
$239K – – –
AAM
171
Aureus Asset Management
Massachusetts
$239K +$216K +6,000 New
ECM
172
ETrade Capital Management
Virginia
$234K +$211K +5,860 New
SO
173
STRS Ohio
Ohio
$231K +$108K +3,000 +107%
BlackRock
174
BlackRock
New York
$207K +$41.2K +1,146 +28%
TRCT
175
Tower Research Capital (TRC)
New York
$196K +$155K +4,308 +718%
5 6
7
8 9

IART Hedge Fund Activity: Q2 2016 in Review

210 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2016, worth a combined $2.67B — up 22% from $2.2B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new IART positions and 16 closed out — a net gain of 18 holders — while 80 added to existing stakes and 71 trimmed.

The largest buyer was RS Investment Management, opening a new position worth an estimated $51.1M. The largest seller was Victory Capital Management, exiting entirely with an estimated $22.1M sold.

  • 210 institutional investors held Integra LifeSciences (IART) as of Q2 2016, up from 194 in Q1 2016.
  • Funds reported $2.67B of Integra LifeSciences stock for Q2 2016, up 22% quarter-over-quarter.
  • 34 funds opened new Integra LifeSciences positions in Q2 2016 and 16 closed out, a net change of +18 holders.
  • The largest Integra LifeSciences buyer in Q2 2016 was RS Investment Management, an estimated $51.1M added.
  • The largest Integra LifeSciences seller in Q2 2016 was Victory Capital Management, an estimated $22.1M sold.

Based on aggregated 13F filings for Q2 2016.